|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Investment in crypto assets – Bitcoin | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Receivable from SPAC IPO Costs | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and stockholders’ deficit | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Loan Amount due to related parties | ||||||||||||||||||||
| Excise tax | ||||||||||||||||||||
| Deferred revenues | ||||||||||||||||||||
| Loan Payable | ||||||||||||||||||||
| Convertible promissory notes | ||||||||||||||||||||
| Canada Emergency Business Loan Act | ||||||||||||||||||||
| Income tax payable | ||||||||||||||||||||
| Loan extensions | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| PIPE Notes | ||||||||||||||||||||
| Yorkville Note | ||||||||||||||||||||
| Loans payable – related parties | ||||||||||||||||||||
| Convertible notes at fair value | ||||||||||||||||||||
| Deferred underwriter fee payable | ||||||||||||||||||||
| Loan – related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total loan – related party | ||||||||||||||||||||
| Line of credit | ||||||||||||||||||||
| Loans – related parties | ||||||||||||||||||||
| Other current liabilities | ||||||||||||||||||||
| 2024 SEPA put option liability | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Convertible promissory note | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total convertible promissory note | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total other long-term liabilities | ||||||||||||||||||||
| Loans payable, net of current portion | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total loans payable, net of current portion | ||||||||||||||||||||
| Warrant liabilities | ||||||||||||||||||||
| SEPA put option liability, net of current portion | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Class A Common Stock subject to possible redemption; 2,731,544 shares at redemption value of $10.96 and $10.53 per share as of June 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Total class A Common Stock subject to possible redemption; 2,731,544 shares at redemption value of $10.96 and $10.53 per share as of June 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Stockholders’ deficit: | ||||||||||||||||||||
| Preferred Stock, par value $0.0001, 1,000,000 shares authorized at June 30, 2026 and December 31, 2025; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Series A-2 Preferred Stock | ||||||||||||||||||||
| Series A-1 Preferred Stock | ||||||||||||||||||||
| Common Stock, par value $0.0001, 100,000,000 shares authorized, 57,909,088 shares issued and 57,721,343 shares outstanding at June 30, 2026, and 51,984,473 shares issued and 51,796,728 shares outstanding at December 31, 2025 | ||||||||||||||||||||
| Total common Stock, par value $0.0001, 100,000,000 shares authorized, 57,909,088 shares issued and 57,721,343 shares outstanding at June 30, 2026, and 51,984,473 shares issued and 51,796,728 shares outstanding at December 31, 2025 | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock, at cost, 187,745 shares at June 30, 2026 and December 31, 2025 | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total liabilities and stockholders’ deficit | ||||||||||||||||||||
Loading...